We are beyond thrilled to share a major milestone for our community—the official launch of the Liposarcoma Support Network Medical Advisory Board!

This groundbreaking step will provide expert guidance, enhance medical understanding, and drive meaningful progress in the fight against liposarcoma.

For too long, individuals affected by liposarcoma have struggled with limited resources, inconsistent medical information, and a lack of dedicated research. By bringing together a team of leading experts—including oncologists, surgeons, radiologists, and pathologists, our Medical Advisory Board (MAB) will serve as a trusted source of medical insight to help us powerfully advocate for the needs of our community.

What Will the Medical Advisory Board Do?

Our MAB will play a critical role in shaping the future of care, research, and awareness by sharing their expertise to provide strategic direction on LSN initiatives to ensure the survival and well-being of liposarcoma patients.

The objectives are to:

Why This is a Game-Changer for Our Community

The creation of this board is historic for all of us. For the first time, we have a dedicated team of medical professionals working specifically for the advancement and support of our disease community. This means more answers, more advocacy, more progress—and most importantly, more hope.

We cannot wait to introduce you to the brilliant minds who will serve on this board. Their guidance will help shape the future of liposarcoma care and bring us closer to better treatments, improved quality of life, and ultimately, a cure.

We are so grateful to everyone who has supported this effort, and we look forward to keeping you updated on the board’s work.

Together, we are stronger—and together, we are changing the future for patients and caregivers.